Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Making sense of ubiquitin ligases that regulate p53.

Jain AK, Barton MC.

Cancer Biol Ther. 2010 Oct 1;10(7):665-72. Epub 2010 Oct 1. Review.

2.

A portrayal of E3 ubiquitin ligases and deubiquitylases in cancer.

Satija YK, Bhardwaj A, Das S.

Int J Cancer. 2013 Dec 15;133(12):2759-68. doi: 10.1002/ijc.28129. Epub 2013 Mar 25. Review.

3.

Limiting the power of p53 through the ubiquitin proteasome pathway.

Pant V, Lozano G.

Genes Dev. 2014 Aug 15;28(16):1739-51. doi: 10.1101/gad.247452.114. Review.

4.

HECT and RING finger families of E3 ubiquitin ligases at a glance.

Metzger MB, Hristova VA, Weissman AM.

J Cell Sci. 2012 Feb 1;125(Pt 3):531-7. doi: 10.1242/jcs.091777. Review. No abstract available.

5.

Ubiquitination of E3 ligases: self-regulation of the ubiquitin system via proteolytic and non-proteolytic mechanisms.

de Bie P, Ciechanover A.

Cell Death Differ. 2011 Sep;18(9):1393-402. doi: 10.1038/cdd.2011.16. Epub 2011 Mar 4. Review.

6.

p53 ubiquitination: Mdm2 and beyond.

Brooks CL, Gu W.

Mol Cell. 2006 Feb 3;21(3):307-15. Review.

7.

p53 regulation by ubiquitin.

Brooks CL, Gu W.

FEBS Lett. 2011 Sep 16;585(18):2803-9. doi: 10.1016/j.febslet.2011.05.022. Epub 2011 May 27. Review.

8.

The multiple levels of regulation by p53 ubiquitination.

Lee JT, Gu W.

Cell Death Differ. 2010 Jan;17(1):86-92. doi: 10.1038/cdd.2009.77. Epub . Review.

9.

Dynamics in the p53-Mdm2 ubiquitination pathway.

Brooks CL, Gu W.

Cell Cycle. 2004 Jul;3(7):895-9. Epub 2004 Jul 2. Review.

PMID:
15254415
10.

ATM-mediated phosphorylations inhibit Mdmx/Mdm2 stabilization by HAUSP in favor of p53 activation.

Meulmeester E, Pereg Y, Shiloh Y, Jochemsen AG.

Cell Cycle. 2005 Sep;4(9):1166-70. Epub 2005 Sep 29. Review.

PMID:
16082221
11.

Mdm2 and MdmX partner to regulate p53.

Wang X, Jiang X.

FEBS Lett. 2012 May 21;586(10):1390-6. doi: 10.1016/j.febslet.2012.02.049. Epub 2012 Mar 8. Review.

12.

Regulation of the p53 pathway by ubiquitin and related proteins.

Hock A, Vousden KH.

Int J Biochem Cell Biol. 2010 Oct;42(10):1618-21. doi: 10.1016/j.biocel.2010.06.011. Epub 2010 Jun 17. Review.

PMID:
20601087
13.

Targeting the ubiquitin-proteasome system to activate wild-type p53 for cancer therapy.

Allende-Vega N, Saville MK.

Semin Cancer Biol. 2010 Feb;20(1):29-39. doi: 10.1016/j.semcancer.2009.10.004. Epub 2009 Nov 6. Review.

PMID:
19897040
14.

The role of ubiquitination in the direct mitochondrial death program of p53.

Marchenko ND, Moll UM.

Cell Cycle. 2007 Jul 15;6(14):1718-23. Epub 2007 May 25. Review.

PMID:
17630506
15.
16.

p53 proteasomal degradation: poly-ubiquitination is not the whole story.

Asher G, Shaul Y.

Cell Cycle. 2005 Aug;4(8):1015-8. Epub 2005 Aug 7. Review.

PMID:
16082197
17.

[The role of different E3 ubiquitin ligases in regulation of the P53 tumor suppressor protein].

Daks AA, Melino D, Barlev NA.

Tsitologiia. 2013;55(10):673-87. Review. Russian.

PMID:
25509121
18.

Regulation of the p53-MDM2 pathway by 14-3-3 sigma and other proteins.

Lee MH, Lozano G.

Semin Cancer Biol. 2006 Jun;16(3):225-34. Epub 2006 Apr 6. Review.

PMID:
16697215
19.

The p53-Mdm2 module and the ubiquitin system.

Michael D, Oren M.

Semin Cancer Biol. 2003 Feb;13(1):49-58. Review.

PMID:
12507556
20.

The p53 response to DNA damage.

Meek DW.

DNA Repair (Amst). 2004 Aug-Sep;3(8-9):1049-56. Review.

PMID:
15279792
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk